Introduction CT density correlates with quality of life (QOL) scores and impaired upper zone lung density associates with higher mortality in alpha one antitrypsin deficiency (A1ATD). We hypothesised that decline in CT densitometry would relate to survival or deterioration in QOL in A1ATD. Methods All augmentation naïve PiZZ patients in the UK A1ATD registry with ≥two successive quantitative CT scans were selected. Patients were divided into groups based on CT density decline and the relationship to survival and change in QOL compared by univariate analyses and multivariate Cox regression. Analyses were performed for whole lung, upper zone and lower zone density separately. Exploratory analyses of FEV1 subgroups were conducted. Results 110 ...
Abstract Background We developed a method to calculate a standard score for lung tissue mass derived...
Background: Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) pr...
SummaryBackgroundFour hundred and eighty-eight PiZ alpha-1-antitrypsin deficient patients, who had j...
Objectives To establish a database network for the study of alpha-1 antitrypsin deficiency (AATD) an...
Background: Lung density measurements by computed tomography have previously been found to be a more...
OBJECTIVES:To establish a database network for the study of alpha-1 antitrypsin deficiency (AATD) an...
Background: Computed tomography (CT) lung densitometry has been demonstrated to be the most sensitiv...
Background: Two randomised, double-blind, placebo-controlled trials have investigated the efficacy o...
Differing emphysema distribution in alpha-1-antitrypsin deficiency (A1AD) relates to specific lung f...
Assessment of emphysema-modifying therapy is difficult, but newer outcome measures offer advantages ...
Background: Lung densitometry derived from computed tomographic images offers an opportunity to quan...
Background: Severe (PiZZ) and moderate (PiSZ) alpha-1-antitrypsin (AAT) deficiency predispose to lun...
Abstract Background Computer tomography (CT) densitometry is a potential tool for detecting the prog...
CT densitometry is the method of quantifying emphysema using specialised software programs, and its ...
SummaryBackgroundSevere (PiZZ) and moderate (PiSZ) alpha-1-antitrypsin (AAT) deficiency predispose t...
Abstract Background We developed a method to calculate a standard score for lung tissue mass derived...
Background: Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) pr...
SummaryBackgroundFour hundred and eighty-eight PiZ alpha-1-antitrypsin deficient patients, who had j...
Objectives To establish a database network for the study of alpha-1 antitrypsin deficiency (AATD) an...
Background: Lung density measurements by computed tomography have previously been found to be a more...
OBJECTIVES:To establish a database network for the study of alpha-1 antitrypsin deficiency (AATD) an...
Background: Computed tomography (CT) lung densitometry has been demonstrated to be the most sensitiv...
Background: Two randomised, double-blind, placebo-controlled trials have investigated the efficacy o...
Differing emphysema distribution in alpha-1-antitrypsin deficiency (A1AD) relates to specific lung f...
Assessment of emphysema-modifying therapy is difficult, but newer outcome measures offer advantages ...
Background: Lung densitometry derived from computed tomographic images offers an opportunity to quan...
Background: Severe (PiZZ) and moderate (PiSZ) alpha-1-antitrypsin (AAT) deficiency predispose to lun...
Abstract Background Computer tomography (CT) densitometry is a potential tool for detecting the prog...
CT densitometry is the method of quantifying emphysema using specialised software programs, and its ...
SummaryBackgroundSevere (PiZZ) and moderate (PiSZ) alpha-1-antitrypsin (AAT) deficiency predispose t...
Abstract Background We developed a method to calculate a standard score for lung tissue mass derived...
Background: Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) pr...
SummaryBackgroundFour hundred and eighty-eight PiZ alpha-1-antitrypsin deficient patients, who had j...